Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susumu Imazu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|February 19, 2003
A novel T7 system utilizing mRNA coding for T7 RNA polymeraseRisako Nakano, Tetsuhiko Nakagawa, Susumu Imazu, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized studyMasahiro Yasaka, Ippei Ikushima, Akiko Harada, et al.
Biological & Pharmaceutical Bulletin|January 6, 2006
Non-methylated CpG motif packaged into fusogenic liposomes enhance antigen-specific immunity in miceTomoaki Yoshikawa, Susumu Imazu, Jian-Qing Gao, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studiesStephen Norris, Steven Ramael, Ippei Ikushima, et al.
Thrombosis and Haemostasis|December 2, 2016
Idarucizumab does not have procoagulant effects: Assessment of thrombosis biomarkers in healthy volunteersMichael Schmohl, Stephan Glund, Akiko Harada, et al.
Journal of Lipid Research|June 9, 2018
Deficient ganglioside synthesis restores responsiveness to leptin and melanocortin signaling in obese KKAy miceKei-Ichiro Inamori, Hideki Ito, Yumi Tamura, et al.
Biochemical and Biophysical Research Communications|November 9, 2004
Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccineTomoaki Yoshikawa, Susumu Imazu, Jian-Qing Gao, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|February 19, 2003
A novel T7 system utilizing mRNA coding for T7 RNA polymeraseRisako Nakano, Tetsuhiko Nakagawa, Susumu Imazu, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized studyMasahiro Yasaka, Ippei Ikushima, Akiko Harada, et al.
Biological & Pharmaceutical Bulletin|January 6, 2006
Non-methylated CpG motif packaged into fusogenic liposomes enhance antigen-specific immunity in miceTomoaki Yoshikawa, Susumu Imazu, Jian-Qing Gao, et al.
British Journal of Clinical Pharmacology|February 24, 2017
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studiesStephen Norris, Steven Ramael, Ippei Ikushima, et al.
Thrombosis and Haemostasis|December 2, 2016
Idarucizumab does not have procoagulant effects: Assessment of thrombosis biomarkers in healthy volunteersMichael Schmohl, Stephan Glund, Akiko Harada, et al.
Journal of Lipid Research|June 9, 2018
Deficient ganglioside synthesis restores responsiveness to leptin and melanocortin signaling in obese KKAy miceKei-Ichiro Inamori, Hideki Ito, Yumi Tamura, et al.
Biochemical and Biophysical Research Communications|November 9, 2004
Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccineTomoaki Yoshikawa, Susumu Imazu, Jian-Qing Gao, et al.
Pageof 1